Genotype-Selective Combination Therapies for Melanoma Identified by High Throughput Drug Screening

Lignende værker

• Phospho-Proteomic Screen Identifies Potential Therapeutic Targets in Melanoma
  af: Tworkoski, Kathryn, et al.
  Udgivet: (2011)
• The Broad Spectrum Receptor Tyrosine Kinase Inhibitor Dovitinib Suppresses Growth of BRAF Mutant Melanoma Cells in Combination with Other Signaling Pathway Inhibitors
  af: Langdon, Casey G., et al.
  Udgivet: (2015)
• MERTK controls melanoma cell migration and survival and differentially regulates cell behavior relative to AXL
  af: Tworkoski, Kathryn A., et al.
  Udgivet: (2013)
• Combinatorial drug screening of mammary cells with induced mesenchymal transformation to identify drug combinations for triple-negative breast cancer
  af: Colavito, Sierra A., et al.
  Udgivet: (2019)
• p90RSK Blockade Inhibits Dual BRAF and MEK Inhibitor-Resistant Melanoma by Targeting Protein Synthesis
  af: Theodosakis, Nicholas, et al.
  Udgivet: (2017)